English   español  
Por favor, use este identificador para citar o enlazar a este item: http://hdl.handle.net/10261/122289
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:

Dipeptidyl peptidase IV dependent water-soluble prodrugs of highly lipophilic bicyclic nucleoside analogues

AutorDiez-Torrubia, Alberto ; Balzarini, Jan; Andrei, G; Snoeck, R.; De Meester, Ingrid; Camarasa Rius, María José ; Velázquez, Sonsoles
Fecha de publicación2011
EditorAmerican Chemical Society
CitaciónJournal of Medicinal Chemistry 54: 1927-1942 (2011)
ResumenWe present the first report of the application of the dipeptidyl peptidase IV (DPPIV/CD26) based prodrug approach to hydroxy-containing drug derivatives. In particular, we applied this strategy to the highly lipophilic antiviral drug family of bicyclic furanopyrimidine nucleoside analogues (BCNA) in order to improve their physicochemical and pharmacokinetic properties. Our stability data demonstrated that the prodrugs efficiently release the parent BCNA drug upon selective conversion by purified DPPIV/CD26 and by soluble DPPIV/CD26 present in bovine, murine, and human serum. Vildagliptin, a specific inhibitor of DPPIV/CD26, was able to completely block the hydrolysis of the prodrugs in the presence of purified DPPIV/CD26 human, murine, and bovine serum. Several novel prodrugs showed remarkable increases in water solubility (up to more than 3 orders of magnitude) compared to the poorly soluble parent drug. We also demonstrated a markedly enhanced oral bioavailability of the prodrugs versus the parent drug in mice.
Versión del editorhttp://dx.doi.org/10.1021/jm101624e
Identificadoresdoi: 10.1021/jm101624e
issn: 0022-2623
e-issn: 1520-4804
Aparece en las colecciones: (IQM) Artículos
Ficheros en este ítem:
No hay ficheros asociados a este ítem.
Mostrar el registro completo

Artículos relacionados:

NOTA: Los ítems de Digital.CSIC están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.